AptarGroup, Inc. (ATR) Financials
ATR Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2024-03-31 | 4.4 billion | 2.1 billion |
2023-12-31 | 4.5 billion | 2.1 billion |
2023-09-30 | 4.3 billion | 2.1 billion |
2023-06-30 | 4.3 billion | 2.2 billion |
ATR Free Cash Flow and Stock based compensation
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2024-03-31 | 16.7 million | 18.3 million |
2023-12-31 | 136.1 million | 5.2 million |
2023-09-30 | 94.9 million | 10.7 million |
2023-06-30 | 6.1 million | 10.4 million |
ATR Net Income
Date | Net Income |
---|---|
2024-03-31 | 83.1 million |
2023-12-31 | 62.2 million |
2023-09-30 | 84.3 million |
2023-06-30 | 83.0 million |
ATR Cash and Debt
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2024-03-31 | 201.1 million | - | 43.6 million |
2023-12-31 | 223.6 million | - | 45.3 million |
2023-09-30 | 151.6 million | 680.1 million | 39.7 million |
2023-06-30 | 121.0 million | 949.9 million | 43.1 million |
ATR Shares Outstanding
ATR Expenses
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2024-03-31 | 75.7 million | 152.8 million | 152.8 million | - |
2023-12-31 | 83.6 million | 138.3 million | 138.3 million | - |
2023-09-30 | 78.5 million | 138.1 million | 138.1 million | - |
2023-06-30 | 77.8 million | 141.4 million | 141.4 million | - |
ATR Cost of Revenue
Date | Revenue | Cost of Revenue |
---|---|---|
2024-03-31 | 915.4 million | 647.1 million |
2023-12-31 | 838.5 million | 526.2 million |
2023-09-30 | 893.0 million | 566.7 million |
2023-06-30 | 895.9 million | 573.7 million |
ATR
List: Champions
Price: $149.72
Dividend Yield: 0.01%
Forward Dividend Yield: 1.10%
Payout Ratio: 38.59%
Dividend Per Share: 1.64 USD
Earnings Per Share: 4.66 USD
P/E Ratio: 32.35
Exchange: NYQ
Sector: Healthcare
Industry: Medical Instruments & Supplies
Volume: 284100
Ebitda: 129.6 millionMarket Capitalization: 9.9 billion
Average Dividend Frequency: 4
Years Paying Dividends: 32
DGR3: -6.50%
DGR5: -0.40%
DGR10: 3.75%
DGR20: 14.71%